Clinical Genitourinary Cancer Volume 19 Issue 1 to 6

Clinical Genitourinary Cancer is a reputable peer-reviewed journal dedicated to advancing the understanding and management of genitourinary cancers. This journal serves as a valuable resource for clinicians and researchers interested in various aspects of clinical and translational research related to genitourinary malignancies.

Key Highlights of Clinical Genitourinary Cancer:

• Comprehensive Coverage: The journal covers a wide range of topics related to genitourinary cancers, including prostate, bladder, kidney, testicular, and other malignancies within the genitourinary system. This comprehensive approach ensures that readers have access to research and insights across the spectrum of genitourinary malignancies.
• Clinical and Translational Research: Clinical Genitourinary Cancer publishes original articles that contribute to both clinical and translational research in the field. This means that the journal provides insights into recent scientific developments and their application in clinical practice and patient care.
• Mechanistic Approaches: The journal welcomes articles that explore mechanistic approaches to understanding genitourinary cancers. This includes investigations into the underlying molecular and cellular mechanisms of these malignancies.
• Drug Sensitivity and Resistance: Authors are encouraged to submit research on drug sensitivity and resistance in genitourinary cancers. Understanding how these cancers respond to treatment and the factors that influence treatment outcomes is crucial for improving patient care.
• Gene and Antisense Therapy: Clinical Genitourinary Cancer considers articles on gene therapy and antisense therapy as potential approaches to treating genitourinary malignancies. These emerging therapeutic strategies are of significant interest to the field.
• Pathology, Markers, and Prognostic Indicators: The journal publishes research related to pathology, biomarkers, and prognostic indicators in genitourinary cancers. These studies contribute to more accurate diagnosis and prognosis, ultimately benefiting patient management.
• Chemoprevention Strategies: Clinical Genitourinary Cancer explores research on chemoprevention strategies designed to reduce the risk of developing genitourinary cancers. Such strategies are essential for cancer prevention and control.
• Multimodality Therapy: The journal covers studies on multimodality therapy approaches, which may involve a combination of treatments such as surgery, radiation therapy, and chemotherapy.
• Integration of Various Approaches: Clinical Genitourinary Cancer encourages research on the integration of various therapeutic and diagnostic approaches to optimize patient outcomes.

Published in English, Clinical Genitourinary Cancer ensures that its research findings are accessible to a global audience of healthcare professionals, researchers, and scientists. It plays a pivotal role in advancing knowledge and enhancing the management of genitourinary cancers.

Volume 19, Issue 1: Pages A1-A12, e1-e62, 1-92 (February 2021)

Volume 19, Issue 2: Pages A1-A6, e63-e148, 93-182 (April 2021)

Volume 19, Issue 3: Pages A1-A10, e149-e192, 183-274 (June 2021)

Volume 19, Issue 4: Pages 275-372 (August 2021)

Volume 19, Issue 5: Pages 373-468 (October 2021)

Volume 19, Issue 6: Pages 469-564 (December 2021)